Atorvastatin Calcium Tablets, USP 40 mg, Rx only, 500-count bottle, Manufactured by: Sun Pharmaceutical Industries Limited Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 63304-829-05
Published March 25, 2020 · Recall initiated: March 9, 2020
Summary
FDA records drug Class II recall D-1047-2020, published March 25, 2020 and initiated March 9, 2020. Recalling firm: Sun Pharmaceutical Industries, Inc.; Status: Terminated; Reported quantity: 1416 bottles; Lot: Lot#: AA33617, Exp 03/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of foreign substance: Foreign matter has been identified as latex glove in one lot of Atorvastatin Calcium Tablets USP 40 mg.
What to do
Voluntary: Firm initiated · Letter
Get an email if ATORVASTATIN CALCIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ATORVASTATIN CALCIUM
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Distributor
- U.S.A. Nationwide
- Lot
- Lot#: AA33617, Exp 03/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAtorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL LaboratoriesNovember 4, 2026
- FDAAtorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-90), b). 500-count(NDCOctober 22, 2025
- FDAAtorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-90), b). 500-count (NDCOctober 22, 2025
- FDAAtorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count bottleOctober 22, 2025
- FDADaytrana (methylphenidate transdermal system) patches, Delivers 30 mg over 9 hours (3.3 mg/hr), 30-count box,March 25, 2020
- FDASolifenacin Succinate Tablets, 5mg, packaged in a) 30-count bottles (NDC 51991-893-33) and b) 90-count bottlesMarch 25, 2020
Questions about this recall
Was Atorvastatin Calcium Tablets, USP 40 mg, Rx only, 500-count bottle, Manufactured by: Sun Pharmaceutical Industries Limited Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 63304-829-05 recalled?
Yes. FDA published recall D-1047-2020 on March 25, 2020. Reported hazard: Presence of foreign substance: Foreign matter has been identified as latex glove in one lot of Atorvastatin Calcium Tablets USP 40 mg.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ATORVASTATIN CALCIUM.